Typhoid vaccine: subcutaneous injection, protective value of 50% for 3 to 6 months Dose: 2 doses at interval of 4 to 6 weeks No practical value during an epidemic, may contribute to occurrence of hep b and polimyelitis Saline preparation of about 12 thousand million cholera vibrios / ml, killed and preserved in 0.5% phenol. Meningococcal vaccine: DNA recombitant, i.e genetically engineered
Typhoid vaccine: subcutaneous injection, protective value of 50% for 3 to 6 months Dose: 2 doses at interval of 4 to 6 weeks No practical value during an epidemic, may contribute to occurrence of hep b and polimyelitis Saline preparation of about 12 thousand million cholera vibrios / ml, killed and preserved in 0.5% phenol. Meningococcal vaccine: DNA recombitant, i.e genetically engineered
Typhoid vaccine: subcutaneous injection, protective value of 50% for 3 to 6 months Dose: 2 doses at interval of 4 to 6 weeks No practical value during an epidemic, may contribute to occurrence of hep b and polimyelitis Saline preparation of about 12 thousand million cholera vibrios / ml, killed and preserved in 0.5% phenol. Meningococcal vaccine: DNA recombitant, i.e genetically engineered